🕵️ Cormedix Inc. ($CRMD)
SEC insider & ownership activity, last 12 months · CIK 1410098 · every row links its SEC filing
Over the last 12 months insiders sold $4.8M against $276K of open-market buying. Janet Dillione sold $1.5M (Nov–Jan). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $276K (1 lots) · 6 sellers, $4.8M (14 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Janet Dillione | 0 | – | 5 | $1.5M | Jan 21, 2026 |
| Todisco Joseph | 0 | – | 2 | $1.0M | Dec 18, 2025 |
| Hurlburt Elizabeth | 0 | – | 2 | $712K | Sep 11, 2025 |
| Zelnick Kaufman Beth | 0 | – | 2 | $670K | Sep 9, 2025 |
| Steven W. Lefkowitz | 0 | – | 1 | $475K | Dec 9, 2025 |
| Alan Dunton | 0 | – | 2 | $391K | Dec 30, 2025 |
| Kaplan Myron | 1 | $276K | 0 | – | Oct 23, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| DEEP Track Capital, LP | 7.9% | 13G | May 15, 2026 | filing ↗ | |
| DEEP Track Biotechnology Master Fund, Ltd. | 7.9% | 13G | May 15, 2026 | filing ↗ | |
| David Kroin | 7.9% | 13G | May 15, 2026 | filing ↗ | |
| Blackrock, Inc. | 7.5% | 13G | Feb 5, 2025 | filing ↗ | |
| Shaibatalhamd Aymen Abdalkader | 5.9% | 13G | Jun 12, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Janet Dillione | $69K | Jan 21, 2026 | filing ↗ |
| Alan Dunton | $259K | Dec 30, 2025 | filing ↗ |
| Joseph Todisco | $359K | Dec 18, 2025 | filing ↗ |
| Steven W. Lefkowitz | $450K | Dec 9, 2025 | filing ↗ |
| Janet Dillione | $408K | Dec 9, 2025 | filing ↗ |
| Janet Dillione | $728K | Nov 24, 2025 | filing ↗ |
| Dillione Janet | $328K | Nov 14, 2025 | filing ↗ |
| Erin Mistry | $149K | Nov 10, 2025 | filing ↗ |
| Erin Mistry | $153K | Nov 6, 2025 | filing ↗ |
| Alan W. Dunton | $131K | Sep 12, 2025 | filing ↗ |
| Todisco Joseph | $649K | Sep 12, 2025 | filing ↗ |
| Zelnick Kaufman Beth | $673K | Sep 9, 2025 | filing ↗ |
| Hurlburt Elizabeth | $729K | Sep 9, 2025 | filing ↗ |
| Matthew T. David | $4.3M | Sep 3, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jun 29, 2026 | filing ↗ |
| Auditor change (4.01) | Jun 25, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 23, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 8, 2026 | filing ↗ |
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 6, 2026 | filing ↗ |
| Earnings (2.02) | Mar 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 5, 2026 | filing ↗ |
| Earnings (2.02) | Jan 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 5, 2026 | filing ↗ |
| Other events (8.01) | Jan 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 5, 2026 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Earnings (2.02) | Oct 20, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 20, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 29, 2025 | filing ↗ |
| Material agreement (1.01) | Aug 28, 2025 | filing ↗ |
| Acquisition or disposition (2.01) | Aug 28, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Aug 28, 2025 | filing ↗ |
| Officer/director changes (5.02) | Aug 28, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 28, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 28, 2025 | filing ↗ |
| Material agreement (1.01) | Aug 12, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Aug 12, 2025 | filing ↗ |